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Background: Formal rehabilitation programs are often assumed to be required after total knee arthroplasty to
optimize patient recovery. Inpatient rehabilitation is a costly rehabilitation option after total knee arthroplasty and, in
Australia, is utilized most frequently for privately insured patients. With the exception of comparisons with domiciliary
services, no randomized trial has compared inpatient rehabilitation to any outpatient based program. The Hospital
Inpatient versus HOme (HIHO) study primarily aims to determine whether 10 days of post-acute inpatient rehabilitation
followed by a hybrid home program provides superior recovery of functional mobility on the 6-minute walk test
(6MWT) compared to a hybrid home program alone following total knee arthroplasty. Secondarily, the trial aims
to determine whether inpatient rehabilitation yields superior recovery in patient-reported function.
Methods/Design: This is a two-arm parallel randomized controlled trial (RCT), with a third, non-randomized,
observational group. One hundred and forty eligible, consenting participants who have undergone a primary total knee
arthroplasty at a high-volume joint replacement center will be randomly allocated when cleared for discharge from
acute care to either 10 days of inpatient rehabilitation followed by usual care (a 6-week hybrid home program) or to
usual care. Seventy participants in each group (140 in total) will provide 80% power at a significance level of 5% to
detect an increase in walking capacity from 400 m to 460 m between the Home and Inpatient groups, respectively, in
the 6MWT at 6 months post-surgery, assuming a SD of 120 m and a drop-out rate of <10%.
The outcome assessor will assess participants at 10, 26 and 52 weeks post-operatively, and will remain blind to group
allocation for the duration of the study, as will the statistician. Participant preference for rehabilitation mode stated prior
to randomization will be accounted for in the analysis together with any baseline differences in potentially confounding
characteristics as required.
Discussion: The HIHO Trial will be the first RCT to investigate the efficacy of inpatient rehabilitation compared to any
outpatient alternative following total knee arthroplasty.
Trial registration: U.S. National Institutes of Health Clinical Trials Registry (http://clinicaltrials.gov) ref: NCT01583153* Correspondence: mark.buhagiar@sswahs.nsw.gov.au
1Braeside Hospital, HammondCare, Locked Bag 82, Wetherill Park 2164, NSW,
Australia
2South West Sydney Clinical School, University of New South Wales,
Liverpool Hospital, Elizabeth Drive, Liverpool, NSW 2170, Australia
Full list of author information is available at the end of the article
© 2013 Buhagiar et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Table 1 Medline search string
No Searches Results
1 Exp rehabilitation/ 147587
2 (rehabilit$ or habilitat$).mp. 115199
3 Exp physical therapy modalities/ 121900
4 (Physical therap$ or physiotherap$).mp. 43406
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In Australia, inpatient rehabilitation is a costly and com-
monly utilized treatment option after total knee arthro-
plasty (TKA), particularly in the private sector. A 12-day
inpatient stay in a private facility costs approximately
AU$8,100 [1]. Based on unpublished data derived from
both the Australian Rehabilitation Outcomes Centre and
the National Joint Replacement Registry, approximately
46% of privately insured patients undergoing knee re-
placement (primary, revision or unicompartmental) in
New South Wales, and 32% of private patients Australia-
wide, received inpatient rehabilitation in the 2011/12
financial year. As the majority of TKA procedures are
performed in the private sector in Australia - some
32,105 per year [2] - the question of whether inpatient
rehabilitation yields superior outcomes to cheaper al-
ternatives is of considerable interest to private health
insurers and governments alike. Inevitably, the cost of
inpatient services is reflected in private insurance pre-
miums and costly premiums negatively affect rates of
private health insurance.5 1 or 2 or 3 or 4 315967
6 Arthroplasty, replacement, knee.mp. 12403
7 Knee prosthesis/ 8491
8 Knee prosthesis/or arthroplasty, replacement,
knee/or knee joint/
49918
9 Exp knee/ 10214
10 Knee/or knee prosthesis/or athroplasty, replacement,
knee/or knee joint/or osteoarthritis, knee/
63871
11 9 or 10 63871
12 Exp arthroplasty/ 38632
13 Joint prosthesis/ 8761
14 (Arthroplast$ or prosthe$ or replac$).mp. 493605
15 12 or 13 or 14 494353
16 11 and 15 21729
17 6 or 7 or 8 or 16 51109
18 Randomized controlled trial.pt. 380312




23 Clinical trials as topic.sh. 173251
24 Trial.ti. 120939
25 18 or 19 or 20 or 21 or 22 or 23 or 24 888705
26 Exp animals/not humans.sh. 4007869
27 25 not 26 819207
28 Meta analysis.mp,pt. or review.pt. or search$.tw. 2047494
29 27 or 28 2732075
30 5 and 17 and 29 1316
31 Limit 30 to english language 1212Total knee arthroplasty and associated costs
Between 2003 and 2012, the number of primary TKA
procedures undertaken in Australia has increased by
83.7% [2]. This increasing surgical volume is consistent
with international trends [3-6]. Demand is increasing
due to advances in surgical technique [7], the ageing
population and, thus, more people with osteoarthritis
(OA), and because consumers are opting for a surgical
solution determined to reduce age-related disability in
an effort to maintain health and standards of living as
they live longer [8,9]. Further increases are expected
[2]; thus, there is growing concern regarding the sus-
tainability and affordability of this type of intervention
both in the public and private sectors. Increased de-
mand in the public sector cannot be readily met be-
cause the supply of services is not driven by demand,
but rather is dictated by governmental policy set within
the context of a fixed proportion of gross domestic
product [8]. Whilst the private sector can adjust more
readily to increases in demand, this inevitably puts up-
ward pressure on private health insurance premiums
[7]. Whilst the TKA procedure is viewed as highly cost
effective in light of the impressive gains in functional
performance and health-related quality of life [10,11],
the acute care and associated rehabilitative costs im-
pose a significant burden on public and private hospital
budgets and resources [12-14]. Not surprisingly, a re-
cent retrospective study from the US concluded that
the cost effectiveness of TKA is reduced if the procedure
is associated with a stay in an inpatient rehabilitation
facility [10].Evidence in support of inpatient rehabilitation after total
knee arthroplasty
A systematic search of MEDLINE, EMBASE and CEN
TRAL healthcare databases - first completed in October
2011 and then again in July 2013 (see Table 1 for search
strings) - revealed that there was no high level evidence to
support the provision of inpatient rehabilitation after TKA
over any outpatient-based alternative. Specifically, no ran-
domized trial has compared inpatient rehabilitation to any
group-based or center-based one-to-one program or a
monitored or unmonitored home program. Two studies
(one review [15] and one randomized controlled trial
(RCT) [16]) undertaken in the US have concluded that
Buhagiar et al. Trials 2013, 14:432 Page 3 of 9
http://www.trialsjournal.com/content/14/1/432inpatient rehabilitation is not superior to domiciliary
rehabilitation (hospital services provided at home). A non-
randomized pilot study in Germany concluded that in-
patient rehabilitation was not more cost effective compared
to outpatient rehabilitation [17]. Longitudinal data from an
Australian cohort [13] observed that patient-reported out-
comes were similar whether or not TKA patients were dis-
charged to inpatient rehabilitation. The authors concluded
that randomized trials were required to explore who, if any
group, benefits most (such as older or more infirm patients)
from inpatient rehabilitation.Evidence in support of non-inpatient modes
of rehabilitation
A recent systematic Cochrane review concluded that
there was insufficient and inconsistent evidence to rec-
ommend any specific type, timing or setting for post-
acute TKA rehabilitation, and there was low therapeutic
validity among trials related to exercise intensity, dosage
and adherence (Westby M, 2013, personal communica-
tion). This included the use of hydrotherapy, one-to-one
or group-based therapy, and even different exercise types
such as those targeting functional movements versus
isolated muscle activity. Notably, most of the studies
reviewed were small (n ≤ 160) and none has simultaneously
compared group-based, one-to-one and home-based
programs. Our own recently completed, comparatively
large RCT (n = 249) [18] provides strong evidence that
a one-to-one outpatient program does not provide
superior patient-reported outcomes compared to less
resource-intensive modes such as group-based or mon-
itored home programs up to 1 year post-surgery. In
addition, similar recovery patterns were observed across
all three study arms in joint range, quadriceps lag, and
timed mobility. The similar recovery patterns were ob-
served despite the fact that access to center-based inter-
ventions - 12 sessions each for either the one-to-one or
group-based study arm - were optimized through the use
of transport and parking concessions. Thus, lack of access
or poor attendance did not explain lack of superiority of
the one-to-one mode.Significance
Based on a recent RCT [18] and the lack of research
evaluating the necessity of inpatient rehabilitation, we
contend that a trial comparing the efficacy of the most
resource-intensive form of rehabilitation delivery after
TKA - inpatient rehabilitation compared to one with
comparatively little resource use such as a monitored
home program - is justified. The study will be a land-
mark study in this area, providing evidence that either
supports or refutes the need for resource intensive in-
patient rehabilitation after TKA.Primary objective
The primary objective of this study is to establish
whether inpatient rehabilitation is beneficial after TKA
for patients with OA who could otherwise be discharged
directly home.
The main hypothesis to be tested by the proposed
study is that TKA recipients who receive inpatient re-
habilitation in addition to participating in a home pro-
gram, compared to patients who participate in a home
program only, will achieve a superior level of mobility at
6 months post-surgery as assessed by the 6-minute walk
test (6MWT).
Trial design and methods
Recruitment and consent
We will recruit 140 participants through the Whitlam
Joint Replacement Centre (WJRC) at Fairfield Hospital
in New South Wales, Australia. Consecutive patients
presenting for primary unilateral TKA will be screened
for eligibility. Patients not participating in the study will
receive usual care (a monitored home program).
To be eligible, participants must meet the following
inclusion criteria:
 Undergoing primary, unilateral elective TKA
 Primary diagnosis of OA as documented in the
medical record
 Willingness to give written informed consent and
willingness to participate in and comply with
the study.
 Age 40 years or over
Exclusion criteria will include:
 A history of a mental illness or a condition which
would interfere with the patient’s ability to
understand the requirements of the study. This may
include, but is not limited to, a history of dementia
or short-term memory impairment secondary to a
cerebrovascular accident.
 A predisposition to be discharged to an inpatient
rehabilitation (or hostel) facility due to lack of social
support (for example, the patient would otherwise
return home with no carer availability) or other
physical impairments (for example, contra lateral
amputated lower limb).
 Patients unable to read English
 Patients unable to perform a home exercise program
without hands-on support from another person
or who are unable to perform the program
without supervision (that is, observation) from
another person.
 Patients restricted to partial or no weight-bearing
through the operated limb post-surgery
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which precludes participation in the planned
rehabilitation programs (for example, they suffer a
stroke or peri prosthetic fracture).
 Pregnancy.
Figure 1 shows the expected flow of participants
through recruitment, assessment, intervention and
follow-up. The co-ordinating investigator (MAB) will
identify potential participants presenting to the WJRC
orthopedic clinic, screening consecutive patients against
the inclusion and exclusion criteria by chart review and
direct questioning. A screening log will be kept, recording
the criteria eliminating all those found to be ineligible. A
second log will be maintained, detailing reasons for unwill-
ingness to consent to participation in the study by other-
wise eligible patients. Those willing to participate will be
asked for informed consent using an approved consent
form and baseline measures will be obtained.
This trial is a two-arm parallel RCT (Figure 1). The
two study groups are: (1) hospital inpatient (HI) and (2)
home-based group (hybrid home program (HO)).
Potential participants who are unwilling to undergo
randomization will be invited to participate in a third, non-
randomized, observational group, who will be followed up
6 months after surgery. This third group will permit the de-
tection of a possible preference effect amongst recruited
participants. If study recruitment is biased towards people
with a preference for inpatient rehabilitation, there is a risk
that participants randomized to the inpatient arm will, in
part, report superior outcomes compared to those random-
ized to the home program because they received theirEnrolment – Baseline 
Preoperative education session or pre-operative
Randomizat
Typically day 3-4 post surgery, w
Discharge from acute care (typicall
Treatment P
            8 weeks
HI Group – 10 days inpatient rehabilitation          
followed by a 6-week home program
Assessments week 10, 26 a
Figure 1 Cohort ascertainment, randomization and study timeline. HIpreferred program. If no such superiority is observed
when we compare those who were randomly allocated
to usual care and preferred inpatient rehabilitation to
those who opted to receive usual care (those in the ob-
servational arm), then it is possible that any preference
effect (if present) is not strong.
The study is expected to take up to 51 months,
consisting of 30 to 33 months for recruitment and
randomization, 12 months for follow-up of the final
participants, and 6 months for analysis.
Randomization and allocation concealment
Randomization will take place following surgery once it
has been confirmed that participants are likely to be
cleared for discharge home by post-operative day 5. If it
is determined that there is a need for rehabilitation at
this time - owing to a post-operative complication - such
patients will not be eligible to participate in the study.
A centralized randomization service will be used for
participant randomization using a 1:1 ratio, providing se-
cure, coded randomization via telephone. Group alloca-
tion, therefore, will be concealed from all parties until
the result of the randomization is known. Participants
will be randomized to one of the two intervention
groups using the method of minimization stratified for
variables that affect the primary outcome (distance
walked in the 6MWT), age (≤68 years, >68 years),
height (≤163 cm, >163 cm), and gender [19].
Blinding
Outcome assessors will be blind to group allocation, and
will not be involved in providing the interventions. Theassessment
 clinic (generally within 2-6 weeks of surgery)
ion
hen medically cleared
y between day 3-6 post-surgery)
hase
 HO Group – monitored home program
commencing 2 weeks after surgery
nd 52 post-surgery
, hospital inpatient rehabilitation; HO, hybrid home program.
Table 2 Outcome measures
Primary outcome measure* Data collection instrument
6 minute walk test* 6 minute walk test;
physical test [19]
Secondary outcome measures
Gait speed 15 m walk test; physical test




Oxford Knee Score (OKS) OKS [23]; patient-rated questionnaire
EQ-5D-5 L EQ-5D-5 L [23]; patient-rated
questionnaire
Knee range of motion <100 degrees, ≥100 degrees
Return to work Self-recorded diary




Self recorded diary; health
system records
*The primary end-point for data analysis is 6 months post-surgery. All outcome
measures will be undertaken pre-surgery, then at 10, 26 and 52 weeks post-
surgery, with the exception of return to work and healthcare consumption and
related costs, which will not be assessed at baseline.
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blinded to intervention, but will not play a part in the
collection or analysis of outcomes, and will only provide
one of the treatment options. Those performing the stat-
istical analyses will be blind to group allocation until the
evaluation is completed.
Interventions
Protocols for the two arms of the study will be described
in a Standard Procedures Manual, available from the co-
ordinating investigator. A guide for tailoring exercise
prescription and advancement, as well as criteria for dis-
continuing allocated interventions, will be included
within these protocols.
Hospital inpatient rehabilitation
Those allocated to HI will be admitted to the adjacent
rehabilitation hospital for 10 days. As per the private
sector, HI participants will receive twice-daily supervised
physiotherapy comprising 1 to 1.5 hour class-based exer-
cises and 1 to 1.5 hour one-to-one therapy. Prior to dis-
charge, participants will be familiarized with the home
program as described below.
Hybrid home program (standard care)
The HO will be based on what is standard care in the
local health district, which is broadly based on the home
program utilized in our most recent RCT [18]. The
original home program was informed by guidelines for
exercise in the elderly [20] and those with osteoarthritis
[21]. Approximately 2 weeks post-surgery, participants
allocated to the HO will attend one group-based out-
patient exercise session in the physiotherapy department
where the home program will be rehearsed and exercises
individualized as required due to co-morbidities. The pro-
gram comprises general aerobic components as well as
general functional and muscle-specific exercises focused
on restoring knee mobility, lower limb strength, and nor-
mal neuromuscular co-ordination and gait patterns.
Participants in both treatment arms will be encouraged
to attend one to two classes from post-operative weeks 3
to 8 to encourage exercise progression and discuss any
ongoing issues with the therapist. Participants will receive
a booklet detailing the home program, and will be permit-
ted to contact the therapist by phone in this period.
All participants will be required to complete a diary
detailing program adherence, healthcare utilization, and
social costs relating to carer-burden. Participant attend-
ance at the outpatient classes will also be obtained from
the treating physiotherapist.
Outcome measures
The primary outcome and most secondary outcomes will
be measured pre-operatively, at week 10 (the time whenthe home program formally ceases), and then at 6 and
12 months post-randomization (Table 2). Assessments will
be performed by an observer blinded to the participants’
study allocation.
Primary
The primary outcome is walking distance at 6 months
post-surgery measured using the 6MWT [24-26]. A
functional outcome based on a physical test is a novel
choice as a primary outcome in this field given that the
convention with most TKA rehabilitation studies is to
focus on patient-reported outcomes [16,25-28]. The
decision to employ measured mobility as the primary
outcome was based on multiple factors. First, functional
mobility is a composite of several factors targeted in
rehabilitation programs after TKA such as lower limb
strength, knee range of motion, and balance [25,26,28-30].
Second, a functional outcome is more likely to be directly
influenced by the intervention (rehabilitation), and the
intervention aims to improve walking. Third, the 6MWT is
highly reproducible within the individual [31]. Fourth, it is
likely to be less susceptible to misinterpretation and less
culturally sensitive than patient-reported outcomes. Fifth,
the test does not appear to suffer from the floor or ceiling
effects associated with many patient-reported outcomes
[21]. Sixth, an observer-measured outcome is less likely to
be influenced by a preference effect compared to a patient-
reported outcome, and this is particularly important when
the intervention under examination cannot be blinded from
the recipient. Together, these attributes mean the results
for our primary outcome should be readily translatable to
any TKA cohort.
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Secondary outcomes comprise both patient-reported and
observer-measured outcomes including a knee pain and
function survey (the Knee injury and Osteoarthritis Out-
come Score (KOOS) [22], knee range of motion (ROM)
(<100 degrees, ≥100 degrees) [32,33], health-related quality
of life (the EQ-5D) [34] and the proportion achieving a gait
speed of 1.2 m/s during a 15 m walk test). Direct health-
care costs will also be captured using diarized recordings
and face-to-face interviews [12,13,15]. Costs recorded will
include visits to health professionals, pathology tests, im-
aging, cost of transport and cost of medication. Indirect
costs including time lost from work for the patient or carer
will also be explored in a secondary analysis. The extent to
which a cost analysis is undertaken will depend on the
availability of funds to perform a comprehensive health
economic analysis.
Baseline and other data
Demographic data (age, gender, height, weight, body mass
index (BMI), level of education, co-morbidities) will be col-
lected at baseline, and complication data (such as presenta-
tion to emergency department, re-admission, re-operation,
knee manipulation, wound infection, venous thrombo-
embolism and death) will be collected until 12 months
post-surgery. Preference for rehabilitation mode (home-
based rehabilitation program, inpatient rehabilitation pro-
gram or either) will be ascertained prior to surgery and
after formal rehabilitation has ceased [35].
Follow-up
A summary of the follow-up schedule is shown in
Figure 1. Researchers will perform assessments at base-
line, 10 weeks, 6 months and 1 year. The co-ordinating
investigator will call each participant within the week
preceding each of their follow-up appointments to pro-
mote participant retention and completion of follow-up.
Sample size
The primary end-point in this trial is functional mobility
at 6 months post-surgery measured using the distance
walked during a 6MWT. Seventy participants in each
group (140 in total) will provide 80% power at a signifi-
cance level of 5% to detect an increase in walking capacity
from 400 m to 460 m between the HO and HI groups,
respectively, in the 6MWT at 6 months post-surgery,
assuming a SD of 120 m and a drop-out rate of <10%. The
SD of 120 is a conservative estimate of the SD of the mean
6MWT at 6 months [18,25]. Using a 0.5SD criterion, this
sample will be powered to detect a moderate effect size of
60 m difference in walking distance. If the actual SD of the
sample collected is smaller than the assumed value, say
100 instead of 120, the study will remain powered to
detect a moderate effect size of 0.5SD.The original plan for the primary outcome was gait
speed (m/s) at 6 months post-surgery, with an initial
sample size powered to detect an absolute difference of
20% in the proportion of participants at 6 months who
achieve the minimum gait speed considered necessary to
cross safely at a pedestrian crossing (that is, 1.2 m/s). In
the absence of other context-specific data, the data used
for this calculation was based on the proportion of TKA
participants (37%) who achieved this average gait speed
at 6 months post-surgery during a 6MWT having partic-
ipated in outpatient-based rehabilitation only [18]. This
calculation assumed that average gait speed during a
6MWT was representative of the average speed a TKA
recipient would achieve during a shorter test, such as
crossing a 4- to 6-lane road (approximately 15 m).
Aware that the assumption may be overly optimistic, we
planned to review - whilst blind to treatment allocation -
the proportion in each group achieving an average gait
speed of 1.2 m/s during the 15 m walk test after the first
15 randomized participants reached the 10-week follow-
up. On review, approximately 70% in each group
achieved the requisite gait speed; hence, to expect in-
patient rehabilitation to secure this gait speed for over
90% of the participants was deemed unrealistic. The pri-
mary outcome remained based around the 6MWT as
originally planned, but was converted to the distance
walked during this same test. To complement the
revised primary outcome, and in the absence of data
describing the minimum clinically important difference
for the 6MWT, we included a sub-study to evaluate the
minimum clinically important difference for measured
mobility in this population.
Data management and analysis
Data management
Data will be sent by blinded assessors to blinded data
entry staff for collation and data entry, with range
checks for data values. All databases will be password
protected and stored in secure areas.
Descriptive analyses at baseline
Comparability of intervention groups will be investigated at
baseline. Descriptive statistics will be presented, including
summary statistics of potential confounding variables.
Analyses subsets
Data analysis will be completed using the principle of
intention-to-treat [36]. We will include all randomized
participants regardless of level of compliance with the
protocol. The primary outcome variable is distance mea-
sured using the outcome of a 6MWT at 26 weeks.
Analysis of covariance will be used for this primary
outcome, with treatment group as the main study
factor and walking distance at baseline, weight, BMI,
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For participants with a missing outcome measure at
26 weeks, an imputation method will be used [37,38].
The secondary outcome variables include the 6MWT
at 10 and 52 weeks post-surgery, the 15 m walk test,
EQ5D, Oxford Knee Score, KOOS and knee ROM at
most post-surgery time points.
Mixed model analyses will be used for the continuous
variables measured repeatedly at 10, 26 and 52 weeks
to estimate the treatment group by time effects. These
analyses incorporate the missing data that may occur at
the follow-up occasions. Baseline measurements of the
outcome variables, together with factors such as weight,
BMI, co-morbidities and patient preference, will be
included as covariates [39]. For the binary outcome
measured at 10, 26 and 52 weeks (knee flexion ≥100
degrees or ≤100 degrees), a Generalized Estimating
Equation model will be used to test the treatment effect,
with the adjustment of the covariates as above.
For the analyses involving the observational arm, the
change score in the primary outcome will be compared
between the observational group and those in the ran-
domized home group adjusting for other covariates. A
lack of significant difference in scores between the two
groups will suggest there is no strong preference effect
in this trial and we may not need to include preference
as a covariate in the RCT analyses. To be consistent with
the two RCT groups, we will aim for a minimum 64
participants in the observational group.
For the sensitivity analysis, the above analysis used for
the primary and secondary outcome variables will be
performed ‘as-treated’, analyzing patients according to
the treatment they actually received and excluding those
with missing outcome measures. It will only include pa-
tients who were compliant with the intervention protocol.
Compliance for the HI group will be defined as attendance
of a minimum of 7 days of inpatient rehabilitation, along
with attendance at no less than two outpatient sessions.
Compliance for the HO group will be defined as attend-
ance at no less than two outpatient sessions. There will be
procedures put in place to minimize loss to follow-up,
such as obtaining multiple contact details at time of con-
sent and reminders that assessments are due. The age,
gender and height of participants will be used as strati-
fication variables in the randomization procedure via a
minimization algorithm. The mixed model analysis indi-
cated above will include these three variables as additional
covariates to incorporate the possible within-treatment
group correlation associated with stratification [39].
Trial organization
Ethical approval and trial status
Ethical approval has been granted by St. Vincent’s Hu-
man Research Ethics Committee for this trial (ethicsreference: 11/125). Patient recruitment remained active
at the time of submission of this protocol.
Trial co-ordination and trial progress
The HIHO trial team is listed in Table 3. The principal
investigator will oversee the trial with the assistance of a
co-ordinating investigator, and lead regular meetings of
the field team and co-investigator group. The progress
of the trial will be monitored and supported by the co-
investigators. The principal and co-ordinating investiga-
tor will design the data collection forms.
The principal investigator will instigate and co-ordinate
the training of the field team and perform audits of
procedures throughout. The co-ordinating investigator will
manage recruitment, data flow, recording and storage. Off
protocol and adverse event reports will be sent to the data
and safety monitoring board, with adverse events investi-
gated as they occur, and reports monitored bimonthly. Ad-
verse events will be independently reviewed by two
members of the HIHO trial team, blind to participant arm
allocation, with a third member to adjudicate in the event
of disagreement.
Data and safety monitoring
An independent data safety monitoring board will be
established to monitor the trial safety and, where appro-
priate, provide advice on issues regarding the scientific
aspects of study conduct (eligibility, recruitment rates,
compliance) and any emerging evidence as it relates to
the trial. This board will comprise a rehabilitation phys-
ician, physiotherapist and a statistician/epidemiologist.
The board will be notified of any adverse events (such post-
operative complications that present after randomization or
any falls whilst attending therapy) and will be required to
decide whether they are related to the trial interventions.
Reference to past incidents of falls during rehabilitation ses-
sions, for example, will be used to guide such decisions. If
there appears to be an atypical trend in adverse events, the
trial will be suspended.
Intervention fidelity
Adherence to the intervention protocols will be facilitated
by collaborative development of the protocol, protocol-
based delivery, a comprehensive manual of standard operat-
ing procedures, training of involved personnel, structured
recording forms, audit, observation and feedback.
Publication policy
Irrespective of outcome, the results of the trial will be
submitted for publication in an appropriate journal. The
principal investigator will be responsible for the compil-
ation of report manuscripts, which the co-investigators
will review and approve prior to submission. Any docu-
ments actuated from sub-studies arising from or related
Table 3 HIHO trial team
Name Role on team Affiliation
Dr. Justine Naylor Principle investigator Whitlam Orthopaedic Research Centre, South West Sydney Local Health
District,
University of New South Wales, Ingham Institute of Applied Medical Research




Professor Ian Harris Co-investigator; Whitlam Orthopaedic Research Centre, South West Sydney Local
Health District,
consultant orthopaedic surgeon University of New South Wales, Ingham Institute of Applied Medical Research




Co-investigator; HammondCare, University of New South Wales, South West
Sydney Local Health District
consultant rehabilitation
specialist
Rachael Wright Outcome assessor South West Sydney Local Health District
Renee Fortunato Outcome assessor South West Sydney Local Health District
Danella Hackett Physiotherapist; South West Sydney Local Health District
baseline assessor
Dimyana Farag Physiotherapist; South West Sydney Local Health District
baseline assessor
HIHO: Hospital Inpatient versus HOme.
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investigator. Other noteworthy contributors to the con-
duct of the HIHO Trial will be listed individually
(Table 3) as an assemblage titled “the HIHO trial team”.
Timetable for the HIHO trial
May 2012 - Ethical approval granted by St. Vincent’s
Human Research Ethics Committee
June 2012 - Recruitment starts
July 2012 - First participant randomized
July 2013 - First participant completes 1-year follow-up
December 2014 - Recruitment completed
March 2015 - Last participant randomized
March 2016 - Last participant completes 1-year follow-up
September 2016 - Analysis and publication of outcome
data
Discussion
The HIHO trial will be the first randomized trial to
compare the effectiveness of inpatient rehabilitation with
a hybrid home exercise program following a TKA for
patients with knee OA. It will address the lack of ran-
domized trials to assess post-surgical outcomes for com-
monly utilized treatment options. The results will help
to establish the best rehabilitation approach for adults
with moderate to severe OA of the knee undergoingTKA who are deemed sufficiently independent to be
discharged directly home.
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